PR Newswire
AUSTIN, Texas, Oct. 16, 2024
MedCana to enter into supply Agreement worth $1.2 - $2.4 million Annually
AUSTIN, Texas, Oct. 16, 2024 /PRNewswire/ -- MedCana (OTC: SFWJ), a leading global infrastructure holding company focused on the pharmaceutical-grade cannabis industry, proudly announces through one of its subsidiaries in Colombia, has entered negotiations with an Australian pharmaceutical firm to supply medical-grade cannabis.
The agreement is projected to provide between $100,000 to $200,000 in monthly revenue once operations begin.
Jose Gabriel Diaz, CEO of MedCana, stated, "This agreement represents a pivotal moment for MedCana as we continue expanding globally to meet the increasing demand for pharmaceutical-grade cannabis."
About SFWJ/Medcana
Software Effective Solutions/MedCana is a holding company focused on developing companies in the agricultural technology and cannabis industries. As MedCana moves forward with its expansion plans, the company remains committed to delivering on its promise of building a solid foundation for the future growth of its holdings.
For more information, please visit: www.MedCana.net
Or connect with us via:
MedCana | LinkedIn
https://X.com/@MedcanaCo
SAFE HARBOR STATEMENT
This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
View original content:https://www.prnewswire.com/news-releases/medcana-subsidiary-in-colombia-enters-negotiations-with-australian-firm-for-pharma-cannabis-supply-302277352.html
SOURCE MedCana
